NYSE : SOLV
Solventum Corporation — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 82.51 USD (Oct 30, 2026, 9:51 AM EDT) · Market cap 14.05B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 13.84B |
| Enterprise Value | 18.74B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 170.22M |
| Shares Outstanding | 170.22M |
| Shares Change (YoY) | +0.20% |
| Shares Change (QoQ) | -1.25% |
| Owned by Insiders (%) | 0.26% |
| Owned by Institutions (%) | 77.63% |
| Float | 144.09M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 9.93 |
| Forward PE | 12.03 |
| PS Ratio | 1.67 |
| Forward PS | 1.66 |
| PB Ratio | 2.88 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 66.24 |
| PEG Ratio | 1.16 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 13.07 |
| EV / Sales | 2.25 |
| EV / EBITDA | 16.45 |
| EV / EBIT | 29.60 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.02 |
| Quick Ratio | 0.50 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | 4.20 |
| Debt / FCF | n/a |
| Interest Coverage | 2.39 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 33.96% |
| Return on Assets (ROA) | 2.70% |
| Return on Invested Capital (ROIC) | 5.52% |
| Return on Capital Employed (ROCE) | 5.98% |
| Weighted Average Cost of Capital (WACC) | 7.04% |
| Revenue Per Employee | $403,712 |
| Profits Per Employee | $69,666 |
| Employee Count | 20,584 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 3.75 |
Taxes
| Measure | Value |
|---|
| Income Tax | 262.00M |
| Effective Tax Rate | 15.45% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +16.55% |
| 50-Day Moving Average | 88.10 |
| 200-Day Moving Average | 78.37 |
| Relative Strength Index (RSI) | 35.25 |
| Average Volume (20 Days) | 1,099,146 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.95M |
| Short Previous Month | 4.86M |
| Short % of Shares Out | 2.91% |
| Short % of Float | 3.44% |
| Short Ratio (days to cover) | 5.04 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 8.31B |
| Gross Profit | 4.55B |
| Operating Income | 633.00M |
| Pretax Income | 1.70B |
| Net Income | 1.43B |
| EBITDA | 1.14B |
| EBIT | 633.00M |
| Earnings Per Share (EPS) | $8.19 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 403.00M |
| Total Debt | 5.30B |
| Net Cash | -4.89B |
| Net Cash Per Share | -$28.74 |
| Equity (Book Value) | 4.80B |
| Book Value Per Share | 28.22 |
| Working Capital | 78.00M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 209.00M |
| Capital Expenditures | -327.00M |
| Depreciation & Amortization | 506.00M |
| Net Borrowing | -2.82B |
| Free Cash Flow | -118.00M |
| FCF Per Share | -$0.69 |
Margins
| Measure | Value |
|---|
| Gross Margin | 54.78% |
| Operating Margin | 7.62% |
| Pretax Margin | 20.41% |
| Profit Margin | 17.26% |
| EBITDA Margin | 13.71% |
| EBIT Margin | 7.62% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.20% |
| Shareholder Yield | -0.20% |
| Earnings Yield | 10.07% |
| FCF Yield | -0.85% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $94.69 |
| Price Target Difference | 16.43% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 2.08% |
| EPS Growth Forecast (3Y) | 8.94% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.74 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |